MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE
Clinical trials for MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS drug trial uses Super-Powered MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years and undergo powerful 7T MRI scans to measure changes in brain volume, lesions, and tissue health. The g…
Matched conditions: MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New CAR-T therapy targets tough MS cases in early safety trial
Disease control Not yet recruitingThis early study tests a new treatment called S103 (BCMA-CAR T cells) in 9 adults with progressive or hard-to-treat multiple sclerosis (MS). The main goal is to see if the treatment is safe and to find the best dose. Researchers will also look for early signs that it might help c…
Matched conditions: MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could Low-Oxygen breathing supercharge gait therapy for MS?
Symptom relief Not yet recruitingThis study tests whether breathing low-oxygen air for short periods right before walking training helps people with multiple sclerosis walk better and farther. Thirty-five participants will receive either the low-oxygen breathing or a sham (placebo) version, followed by treadmill…
Matched conditions: MULTIPLE SCLEROSIS (MS) PRIMARY PROGRESSIVE
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC